ASTERDM - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.9
| Stock Code | ASTERDM | Market Cap | 27,968 Cr. | Current Price | 540 ₹ | High / Low | 732 ₹ |
| Stock P/E | 84.8 | Book Value | 85.6 ₹ | Dividend Yield | 0.93 % | ROCE | 139 % |
| ROE | 200 % | Face Value | 10.0 ₹ | DMA 50 | 599 ₹ | DMA 200 | 593 ₹ |
| Chg in FII Hold | -0.26 % | Chg in DII Hold | -0.20 % | PAT Qtr | 58.9 Cr. | PAT Prev Qtr | 105 Cr. |
| RSI | 35.4 | MACD | -18.1 | Volume | 18,24,818 | Avg Vol 1Wk | 11,08,850 |
| Low price | 386 ₹ | High price | 732 ₹ | PEG Ratio | 0.28 | Debt to equity | 0.28 |
| 52w Index | 44.3 % | Qtr Profit Var | -11.7 % | EPS | 5.86 ₹ | Industry PE | 43.3 |
📊 Analysis: ASTERDM is trading at ₹540, below both its 50 DMA (₹599) and 200 DMA (₹593), reflecting short-term weakness. RSI at 35.4 indicates oversold conditions, while MACD (-18.1) shows bearish momentum. Intraday volume (18.2 lakh) is higher than the weekly average (11.0 lakh), suggesting strong participation despite weakness. Fundamentals appear distorted with unusually high ROCE (139%) and ROE (200%), but quarterly PAT declined from ₹105 Cr. to ₹58.9 Cr. (-11.7%). Valuation is stretched (P/E 84.8 vs industry 43.3), though PEG ratio (0.28) suggests growth-adjusted value. Intraday trading potential exists, but risk is elevated.
💡 Optimal Buy Price: ₹535–540 if price consolidates near support.
🎯 Profit-Taking Levels: ₹555–560 (short-term resistance zone).
🛡️ Stop-Loss: ₹525 to protect against downside risk.
⏱️ Exit Strategy (if already holding): Exit if price fails to sustain above ₹555 with strong volume. RSI indicates oversold territory, so a short-term bounce is possible, but weak fundamentals suggest booking profits quickly.
Positive
- EPS of ₹5.86 provides earnings visibility.
- PEG ratio of 0.28 indicates reasonable valuation relative to growth.
- Debt-to-equity ratio of 0.28 shows moderate leverage risk.
- Strong intraday volume above weekly average indicates active participation.
- 52-week index return of 44.3% reflects investor interest.
Limitation
- Trading below both 50 DMA and 200 DMA, showing bearish trend.
- Quarterly PAT declined from ₹105 Cr. to ₹58.9 Cr. (-11.7%).
- High P/E (84.8) compared to industry average (43.3).
- RSI near oversold levels, risk of volatility.
- FII (-0.26%) and DII (-0.20%) holdings decreased, showing reduced institutional support.
Company Negative News
- Quarterly profit decline raises caution over earnings stability.
Company Positive News
- Strong historical returns (52-week index +44.3%).
- PEG ratio suggests growth-adjusted valuation is favorable despite high P/E.
Industry
- Industry P/E at 43.3 indicates sector is moderately valued compared to ASTERDM’s stretched valuation.
- Healthcare sector benefiting from rising demand and expansion opportunities.
Conclusion
⚖️ ASTERDM shows speculative intraday potential due to oversold RSI and strong volume, but weak fundamentals and stretched valuations raise caution. Entry near ₹535–540 with profit-taking around ₹555–560 is optimal. Traders should remain vigilant and exit quickly if momentum fades.